OKUROnKure Therapeutics, Inc.
Earnings
When OnKure Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.
27 quarters. Mar 31, 2020 to Sep 30, 2026. mixed units.
Next results · Q4 2026Projected
Mar 11, after the close
Thu, Mar 11, 2027in 113 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 8 – Apr 1
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Net income
- -$13.50M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- —
- —
- Net income
- -$17.85M
- N/M
- EPS
- -$0.36
- N/M
- Revenue
- —
- —
- Net income
- -$15.35M
- N/M
- EPS
- -$0.31
- N/M
- Revenue
- —
- —
- Net income
- -$15.16M
- N/M
- EPS
- -$1.11
- N/M
- Revenue
- —
- —
- Net income
- -$13.50M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 4, 2026 · after-hours | Nov 4, 2026 | 35 d | 10-Q | — | — | -$0.36 | 2.7% | |
| Q2 2026 | Jun 30, 2026 | Aug 4, 2026 · after-hours | Aug 4, 2026 | 35 d | 10-Q | — | — | -$0.31 | +1.5% | |
| Q1 2026 | Mar 31, 2026 | May 5, 2026 · after-hours | May 5, 2026 | 35 d | 10-Q | — | — | -$1.11 | 10.4% | |
| FY 2025 | ||||||||||
| Q4 2025 | Dec 31, 2025 | Mar 12, 2026 · after-hours | Mar 12, 2026 | 71 d | 10-K | — | — | — | +7.5% | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · after-hours | Nov 6, 2025 | 37 d | 10-Q | — | — | -$1.09 | 4.1% | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · after-hours | Aug 12, 2025 | 43 d | 10-Q | — | — | -$1.14 | +20.0% | |
| Q1 2025 | Mar 31, 2025 | May 5, 2025 · after-hours | May 6, 2025 | 36 d | 10-Q | — | — | -$1.19 | 10.8% | |
| FY 2024 | ||||||||||
| Q4 2024 | Dec 31, 2024 | Mar 10, 2025 · after-hours | Mar 10, 2025 | 69 d | 10-K | — | — | — | +1.0% | |
| Q3 2024 | Sep 30, 2024 | — | Nov 7, 2024 | 38 d | 10-Q | — | — | -$36.55 | +1.0% | |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 · after-hours | Aug 13, 2024 | 44 d | 10-Q | — | — | -$44.82 | — | |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 · after-hours | May 7, 2024 | 37 d | 10-Q | — | — | -$30.37 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 28, 2024 · after-hours | Mar 28, 2024 | 88 d | 10-K | — | — | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 · after-hours | Nov 13, 2023 | 44 d | 10-Q | — | — | -$5.68 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 10, 2023 · after-hours | Aug 10, 2023 | 41 d | 10-Q | — | — | -$0.65 | — | |
| Q1 2023 | Mar 31, 2023 | May 11, 2023 · after-hours | May 11, 2023 | 41 d | 10-Q | — | — | -$0.60 | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 27, 2023 · after-hours | Mar 27, 2023 | 86 d | 10-K | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 8, 2022 | 39 d | 10-Q | — | — | -$0.53 | — | |
| Q2 2022 | Jun 30, 2022 | Aug 9, 2022 · after-hours | Aug 9, 2022 | 40 d | 10-Q | — | — | -$0.50 | — | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · after-hours | May 10, 2022 | 40 d | 10-Q | — | — | -$0.53 | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Mar 23, 2022 · after-hours | Mar 23, 2022 | 82 d | 10-K | — | — | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 11, 2021 · after-hours | Nov 12, 2021 | 43 d | 10-Q | — | — | -$0.52 | — | |
| Q2 2021 | Jun 30, 2021 | Aug 10, 2021 · after-hours | Aug 11, 2021 | 42 d | 10-Q | — | — | -$0.43 | — | |
| Q1 2021 | Mar 31, 2021 | May 19, 2021 · after-hours | May 20, 2021 | 50 d | 10-Q | — | — | -$3.48 | — | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | — | — | -$2.48 | — | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | — | — | -$1.82 | — | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | — | — | -$2.20 | — | |
Earlier years, FY 2020 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
OnKure Therapeutics, Inc. · CIK 1637715 · Engraved from SEC EDGAR